Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,600 GBX | +1.01% | -2.80% | +10.16% |
Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.16% | 80.65B | |
+25.79% | 672B | |
+24.08% | 550B | |
-6.67% | 351B | |
+14.81% | 317B | |
+6.75% | 292B | |
+3.23% | 211B | |
+0.52% | 203B | |
-10.66% | 144B | |
-8.02% | 141B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Sector Update: Health Care